Prothena
focuses on the development of novel protein immunotherapies for the treatment of cell adhesion... Read moreProthena
focuses on the development of novel protein immunotherapies for the treatment of cell adhesion... Read more
News
May 11, 2026
Yahoo
Prothena: Earnings Beat: Prothena Corporation plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 08, 2026
Yahoo
Prothena: Prothena Posts Q1 Earnings as Revenues Surge on Milestone Payment
May 07, 2026
FinanzNachrichten
Prothena: Prothena Corporation plc: Prothena Reports First Quarter 2026 Financial Results and Business Highlights
Apr 30, 2026
City A.M.
Prothena: Prothena to Report First Quarter 2026 Financial Results on May 7
Apr 27, 2026
Investing.com
Prothena: Novo Nordisk gets FDA fast track status for ATTR heart disease drug
Apr 10, 2026
FinanzNachrichten
Prothena: Prothena Corporation plc: Prothena Announces Leadership Team Updates
Mar 21, 2026
FinanzNachrichten
Prothena: Prothena Corporation plc: Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson's and Alzheimer's Disease at AD/PD 2026
Mar 09, 2026
City A.M.
Prothena: Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy
Mar 04, 2026
Owler
Prothena Corporation plc: Prothena's employee count changed from 163 in Dec 2024 to 67 in Dec 2025
Mar 03, 2026
Seeking Alpha
Prothena: Prothena: A Hold With 2 Late-Stage Programs Underway But With Caution
Prothena Competitors
1
2
3
4
5
6
7
8
9
10